Iraqi Journal of Hematology

Wolters Kluwer Medknow Publications

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Iraqi Journal of Hematology is an open-access journal published by Wolters Kluwer Medknow Publications in India, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wolters Kluwer Medknow Publications
ISSN
2072-8069 · 2543-2702
Country
India
Languages
english
Access
Open access
Articles in DOAJ
361
Declared review time
19 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2018-05-16
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
19 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

361

Most recent article

7 months ago

Average review time (journal-declared via DOAJ)

19weeks

Works in OpenAlex

398

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

10

i10-index

12

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2024-08-08
Added to DOAJ
2018-05-16
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
100%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity2
Alternate titles
IJHAl-mağallaẗ al-ʿirāqiyyaẗ li-amrāḍ al-damm
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs

LCC codes

RC633-647.5

Subject areas

  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Blood groups and transfusion
  • Hematological disorders and diagnostics
Show all subjects (75)
  • Iron Metabolism and Disorders
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Platelet Disorders and Treatments
  • Iron Metabolism and Disorders
  • Iron Metabolism and Disorders
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Blood groups and transfusion
  • Blood groups and transfusion
  • Retinoids in leukemia and cellular processes
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia research
  • Blood transfusion and management
  • Hematological disorders and diagnostics
  • Hematological disorders and diagnostics
  • Platelet Disorders and Treatments
  • Platelet Disorders and Treatments
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Hemophilia Treatment and Research
  • Blood donation and transfusion practices
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Blood Coagulation and Thrombosis Mechanisms
  • Multiple Myeloma Research and Treatments
  • Viral-associated cancers and disorders
  • Clinical Laboratory Practices and Quality Control
  • Protein Tyrosine Phosphatases
  • Blood donation and transfusion practices
  • Immunodeficiency and Autoimmune Disorders
  • Blood transfusion and management
  • Blood properties and coagulation
  • Blood donation and transfusion practices
  • Complement system in diseases
  • Immunodeficiency and Autoimmune Disorders
  • Blood properties and coagulation
  • Blood transfusion and management
  • Blood properties and coagulation
  • Inflammatory Biomarkers in Disease Prognosis
  • Hematopoietic Stem Cell Transplantation
  • Hemophilia Treatment and Research
  • Eosinophilic Disorders and Syndromes
  • Hemophilia Treatment and Research
  • Malaria Research and Control
  • Eosinophilic Disorders and Syndromes
  • Hematopoietic Stem Cell Transplantation
  • Inflammatory Biomarkers in Disease Prognosis
  • Inflammatory Biomarkers in Disease Prognosis
  • Viral-associated cancers and disorders
  • COVID-19 Clinical Research Studies
  • Hematopoietic Stem Cell Transplantation
  • Viral-associated cancers and disorders
  • Childhood Cancer Survivors' Quality of Life
  • Venous Thromboembolism Diagnosis and Management
  • Neutropenia and Cancer Infections
  • Childhood Cancer Survivors' Quality of Life
  • COVID-19 Clinical Research Studies
  • Venous Thromboembolism Diagnosis and Management
  • Neutropenia and Cancer Infections

Keywords (DOAJ)

  • hematology
  • internal medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: